Skip to main content
. 2023 Mar 2;2023(3):CD008168. doi: 10.1002/14651858.CD008168.pub2

Taheritafti 2019.

Study characteristics
Methods Single‐centre, randomised controlled trial conducted in Iran
Participants Inclusion criteria: term infants (gestational age ≥ 37 weeks); (quote:) "non‐haemolytic hyperbilirubinaemia" 
Exclusion criteria: haemolytic anaemia; prematurity; sepsis; severe hyperbilirubinaemia (total bilirubin > 18 mg/dL); conjugated hyperbilirubinaemia; onset of jaundice within first 24 hours of life
Interventions Total N = 60 
Group 1 (n = 30): continuous phototherapy 
Group 2 (n = 30): intermittent phototherapy (18 hours on, 8 hours off)
Phototherapy was continued until total serum bilirubin  < 11 mg/dL (breaks up to 1 hour allowed during breastfeeding, changing and changing of diapers (both groups))
Outcomes Primary outcomes
  • Total bilirubin after 6 hours of phototherapy

  • Melatonin levels


Secondary outcomes
  • Kernicterus

  • Complications

  • Duration of phototherapy

  • Length of hospital stay


Other reported outcomes
  • Total bilirubin after 24 hours of phototherapy

  • Total bilirubin after 36 hours of phototherapy

Notes IRCT registration number: IRCT2015112225184N1
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Low risk Quote: "neonates via block randomization were divided into two groups".
Allocation concealment (selection bias) Unclear risk Allocation concealment not described
Blinding (performance bias and detection bias)
All outcomes Low risk Unblinded study with objective outcome measures
Blinding of participants and personnel (performance bias)
All outcomes Low risk Unblinded study with objective outcome measures
Blinding of outcome assessment (detection bias)
All outcomes Low risk Unblinded study with objective outcome measures
Incomplete outcome data (attrition bias)
All outcomes Low risk Complete outcome data provided for all infants
Selective reporting (reporting bias) High risk Reported bilirubin levels at different time points to prespecified time points in trial registry; trial registered during recruitment phase 
Other bias Low risk No other potential sources of bias were identified.